nach oben

Erschienen in:

01.04.2024 | News item

Ezetimibe-related liver injury, SJS, TEN and DRESS

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

The Government of Canada has published a health professional risk communication advising of the risks of ezetimibe [Ezetrol]-related drug-induced liver injury (DILI) and severe cutaneous adverse reactions (SCARs) including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) and drug reaction with eosinophilic and systemic symptoms (DRESS) syndrome. …

Ezetrol (ezetimibe) and the Risks of Drug-Induced Liver Injury and Severe Cutaneous Adverse Reactions Internet Document : 27 Mar 2024. Available from: URL: https://recalls-rappels.canada.ca/en/alert-recall/ezetrol-ezetimibe-and-risks-drug-induced-liver-injury-and-severe-cutaneous-adverse

Titel: Ezetimibe-related liver injury, SJS, TEN and DRESS
Publikationsdatum: 01.04.2024
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-55383-x

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Ezetimibe-related liver injury, SJS, TEN and DRESS

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2024

Antiretrovirals

Ibrutinib

Capecitabine, risk of metabolic acidosis

Influenza-virus-vaccine

Multiple drugs

Bendamustine/filgrastim/paracetamol